$ALGS 8-K SEC Filings

Filed On	Filing
15 Sep 2026	8-K: Entry into a Material Definitive Agreement On September 10, 2026, Aligos Therapeutics, Inc. (the “Company”) entered into the First Amendment to Lease (the “First Amendment”) with Britannia Biotech Gateway Limited Partnership (the “Landlord”), to amend the Lease, dated as of June ...
06 Aug 2026	8-K: Results of Operations and Financial Condition
26 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
07 May 2026	8-K: Results of Operations and Financial Condition
21 Apr 2026	8-K: Entry into a Material Definitive Agreement
14 Apr 2026	8-K: Other Events
05 Mar 2026	8-K: Results of Operations and Financial Condition
04 Feb 2026	8-K: Departure/Election of Directors or Officers; Compensation
06 Nov 2025	8-K: Results of Operations and Financial Condition
06 Aug 2025	8-K: Results of Operations and Financial Condition
26 Jun 2025	8-K: Departure/Election of Directors or Officers; Compensation; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more
06 May 2025	8-K: Results of Operations and Financial Condition
10 Mar 2025	8-K: Results of Operations and Financial Condition
12 Feb 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
03 Feb 2025	8-K: Departure/Election of Directors or Officers; Compensation
06 Nov 2024	8-K: Results of Operations and Financial Condition
05 Sep 2024	8-K: Other Events
19 Aug 2024	8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year
08 Aug 2024	8-K: Departure/Election of Directors or Officers; Compensation
06 Aug 2024	8-K: Results of Operations and Financial Condition

Comments